Skip to content
Researchers & MIT Community
Protect
Submit Disclosure
IPIA & Ownership
Understanding Intellectual Property
Tangible Property Licensing
Software & Open Source Protection
Learn
Technology Transfer Overview
Patenting & Commercializing Your Invention
Choosing Vendors & Merchandise
Learn More about IP
Connect
Connect with Your Licensing Officer
Office Hours
Events
Contact Us
Industry & Entrepreneurs
License
Browse Available Technologies
Technology Portfolios
Start the Licensing Process
License MIT’s Trademark
Understanding Expedited Licenses
Learn
Understanding the Licensing Process
Entrepreneurs & Startups
Meet MIT Researchers
Browse Startups
Learn More about IP
Connect
Connect with a Licensing Officer
Contact Us
Impact
About
Our Team
Join Our Mailing List
Annual Reports
Career Opportunities & Internships
FAQs
Submit Disclosure
Browse Technologies
Understand IP
Resources
News
Events
Our Team
Contact
Search
Content type
Search technologies only
Researchers & MIT Community
Protect
Submit Disclosure
IPIA & Ownership
Understanding Intellectual Property
Tangible Property Licensing
Software & Open Source Protection
Learn
Technology Transfer Overview
Patenting & Commercializing Your Invention
Choosing Vendors & Merchandise
Learn More about IP
Connect
Connect with Your Licensing Officer
Office Hours
Events
Contact Us
Industry & Entrepreneurs
License
Browse Available Technologies
Technology Portfolios
Start the Licensing Process
License MIT’s Trademark
Understanding Expedited Licenses
Learn
Understanding the Licensing Process
Entrepreneurs & Startups
Meet MIT Researchers
Browse Startups
Learn More about IP
Connect
Connect with a Licensing Officer
Contact Us
Impact
About
Our Team
Join Our Mailing List
Annual Reports
Career Opportunities & Internships
FAQs
Submit Disclosure
Browse Technologies
Understand IP
Resources
News
Events
Our Team
Contact
Search
Content type
Search technologies only
Anti-Ebola Neutralizing
Antibodies
Technology /
Case number:
#17334
Ram Sasisekharan / Devin Quinlan / Vidya Subramanian / Kannan Tharakaraman
Technology Areas:
Diagnostics / Drug Discovery and Research Tools / Therapeutics
Impact Areas:
Healthy Living
License
The Design of DNA-scaffolded Subunit Vaccines for Enhanced Germinal Center Responses in HIV
Vaccination
Technology /
Case number:
#25982H
Darrell J Irvine / Anna Romanov / Grant Knappe / Mark Bathe
Technology Areas:
Drug Discovery and Research Tools / Therapeutics
Impact Areas:
Advanced Materials
License
mRNA Subunit Vaccines for African Swine
Fever
Technology /
Case number:
#25930
Jianzhu Chen / Fangfeng Yuan / Junru Cui
Technology Areas:
Drug Discovery and Research Tools / Therapeutics
Impact Areas:
Healthy Living
License
Vaccine Targeting to Mucosal Lymphoid Tissues in the Gastrointestinal
Tract
Technology /
Case number:
#25463H
Darrell J Irvine / Ozgun Kocabiyik
Technology Areas:
Chemicals & Materials / Drug Delivery / Therapeutics
Impact Areas:
Healthy Living
License
Ionizable Lipids for Messenger RNA
Delivery
Technology, Tangible Property /
Case number:
#24861
Daniel Anderson / Idris Raji / Jacob Witten
Technology Areas:
Chemicals & Materials / Drug Delivery / Drug Discovery and Research Tools / Therapeutics
Impact Areas:
Healthy Living
License
Anti-Zika Virus
Antibodies
Technology /
Case number:
#18525J
Ram Sasisekharan / Subhash Vasudevan / Satoru Watanabe / Kuan Chan / Eng Ooi / Kannan Tharakaraman
Technology Areas:
Drug Delivery / Therapeutics
Impact Areas:
Healthy Living
,
Uncharted Frontiers
License
Augmentation of T and B Cell Activation with a Novel Cysteine Protease Linker
Sequence
Technology /
Case number:
#25338
Tyler Jacks / Sean-Luc Shanahan
Technology Areas:
Chemicals & Materials / Therapeutics
Impact Areas:
Healthy Living
License
Programmable Immunostimulation with Structured DNA
Nanoparticles
Technology /
Case number:
#24273H
Darrell J Irvine / Benjamin Read / Eike-Christian Wamhoff / Tyson Moyer / Rebecca Du / Remi Veneziano / Mark Bathe
Technology Areas:
Chemicals & Materials / Therapeutics
Impact Areas:
Healthy Living
License
Recombinant Transmembrane Domain-Deficient STING as Biomimetic Protein Carrier for cGAMP Enhanced Cancer
Immunotherapy
Technology /
Case number:
#25012
Paula Hammond / Celestine Jia Huey Hong / Shengnan Huang / Yanpu He / Jiahe Li / Angela Belcher
Technology Areas:
Biotechnology / Therapeutics
Impact Areas:
Healthy Living
License
RNA-Loaded Lipid Nanoparticle
(LNP)
Technology, Tangible Property /
Case number:
#24973H
Darrell J Irvine / B.j. Kim
Technology Areas:
Biotechnology / Drug Delivery / Therapeutics
Impact Areas:
Healthy Living
License
Pagination
Previous page
‹‹
Page 2
Next page
››
Subscribe to Vaccines